Evaluating effects of penicillin treatment on the metabolome of rats

•Metabolomics was employed to evaluate effects of penicillin on gut microbiota host.•PLS-DA scores plots showed dose- and time-dependent grouping patterns.•Host-gut microbiota urinary co-metabolites decreased in PEN-treated rats.•Urinary conjugated metabolites decreased in PEN-treated rats.•Amino ac...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2013-08, Vol.932, p.134-143
Hauptverfasser: Sun, Jinchun, Schnackenberg, Laura K., Khare, Sangeeta, Yang, Xi, Greenhaw, James, Salminen, William, Mendrick, Donna L., Beger, Richard D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Metabolomics was employed to evaluate effects of penicillin on gut microbiota host.•PLS-DA scores plots showed dose- and time-dependent grouping patterns.•Host-gut microbiota urinary co-metabolites decreased in PEN-treated rats.•Urinary conjugated metabolites decreased in PEN-treated rats.•Amino acids, bile acids and nucleotides in urine were altered in treated rats. Penicillin (PEN) V, a well-known antibiotic widely used in the treatment of Gram-positive bacterial infections, was evaluated in this study. LC/MS- and NMR-based metabolic profiling were employed to examine the effects of PEN on the host's metabolic phenotype. Male Sprague Dawley rats were randomly divided into groups that were orally administered either 0.5% methylcellulose vehicle, 100 or 2400mg PEN/kg body weight once daily for up to 14 consecutive days. Urine, plasma and tissue were collected from groups sacrificed at 6h, 24h or 14d. The body fluids were subjected to clinical chemistry and metabolomics analysis; the tissue samples were processed for histopathology. The only notable clinical chemistry observation was that gamma glutamyltransferase (GGT) significantly decreased at 24h for both dose groups, and significantly decreased at 14d for the high-dose groups. Partial least squares discriminant analysis scores plots of the metabolomics data from urine and plasma samples showed dose- and time-dependent grouping patterns. Time- and dose-dependent decreases in urinary metabolites including indole-containing metabolites (such as 3-methyldioxyindole sulfate generated from bacterial metabolism of tryptophan), organic acids containing phenyl groups (such as hippuric acid, phenyllactic acid and 3-hydroxyanthranilic acid), and metabolites conjugated with sulfate or glucuronide (such as cresol sulfate and aminophenol sulfate) indicated that the gut microflora population was suppressed. Decreases in many host-gut microbiota urinary co-metabolites (indole- and phenyl-containing metabolites, amino acids, vitamins, nucleotides and bile acids) suggested gut microbiota play important roles in the regulation of host metabolism, including dietary nutrient absorption and reprocessing the absorbed nutrients. Decreases in urinary conjugated metabolites (sulfate, glucuronide and glycine conjugates) implied that gut microbiota might have an impact on chemical detoxification mechanisms. In all, these results clearly show that metabolic profiling is a useful tool to better understand the effects of the antibi
ISSN:1570-0232
1873-376X
DOI:10.1016/j.jchromb.2013.05.030